Radikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $260,513 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics announces hiring of Zsuzsanna Zsellenger, M.D., Ph.D. as...
WEST TISBURY, Massachusetts – February 18, 2013 Radikal Therapeutics today announced that the Company has been joined by Dr. Zsuzsanna Zsengeller, who will assume responsibility for histology and...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $269,865 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $245,133 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $266,919 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 2 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $2,163,046 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $378,009 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation Research grant...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $296,339 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics awarded Phase 1 Small Business Innovation grant by the...
WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the National Institutes of Health has awarded the Company $308,160 for investigation of a novel series of small molecule...
View ArticleRadikal Therapeutics announces hiring of C. Edwin Garner, Ph.D. as Director...
WEST TISBURY, Massachusetts – January 01, 2014 Radikal Therapeutics today announced that the Company has been joined by Dr. C. Edwin Garner, Ph.D. who will be responsible for the design and conduct of...
View ArticleRadikal Therapeutics awarded funding by Health and Human Services (HHS) for...
October 3, 2016 WEST TISBURY, Massachusetts Radikal Therapeutics today announced that the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response...
View Article